ALP's European Gamble: A Nicotine Disruptor Fueled by Media and Muscle

LONDON, UK – July 23, 2026 – In a move that signals a new front in the global nicotine wars, upstart American brand ALP has officially launched its products in the UK and European Union. Backed by a unique and potent combination of established industry players, new media influence, and celebrity firepower, the company is betting it can replicate its disruptive US success in one of the world's most competitive and complex markets. This isn't just a product launch; it's a calculated assault on an industry dominated by giants, and its success or failure will offer a masterclass in modern brand building and market entry.

The press release paints a picture of meteoric growth. Founded just two years ago in late 2024, ALP bypassed traditional retail channels, building its brand directly with consumers online. This direct-to-consumer (DTC) strategy allowed it to become the number one DTC nicotine pouch brand in the US before making a spectacular pivot to physical stores. According to Nielsen data cited by the company, this retail rollout saw ALP capture nearly 1% of all US convenience store nicotine pouch sales in less than 90 days—a staggering velocity for a new entrant in a market valued at over $2.4 billion in 2025.

Now, ALP is bringing this playbook to Europe, rolling out across 11 markets with the audacious goal of becoming one of the continent's largest brands by 2030. "We've built exceptional momentum in the United States by delivering on an excellent customer experience and focusing obsessively on our community's feedback," said CEO and Co-founder Lorenzo De Plano. This expansion is the story behind the numbers, revealing a fascinating intersection of finance, media, and industrial transformation.

The European Battlefield

ALP is not entering a vacuum. The European nicotine pouch market, valued at approximately $2.47 billion, is a mature and fiercely contested battlefield. The landscape is dominated by two titans: Philip Morris International's ZYN, which holds a commanding 35% market share, and British American Tobacco's VELO, with 28%. These incumbents have deep pockets, vast distribution networks, and years of experience navigating the continent's patchwork of regulations.

Europe's regulatory environment is a minefield. Unlike the US, there is no single, harmonized law governing nicotine pouches. While countries like Sweden and the UK permit their sale under specific rules, others have enacted outright bans. Belgium banned the products in 2023, with the Netherlands and France following suit in 2025. Germany employs a de facto ban by classifying them as an 'unauthorized novel food ingredient'. This fragmented landscape requires a nimble and resource-intensive strategy, making ALP's 11-market rollout ambitious.

Furthermore, the regulatory walls are closing in. A new EU Tobacco Products Directive (TPD3), expected to formally regulate nicotine pouches at the EU level around 2028, looms on the horizon. In the UK, the Tobacco and Vapes Act will impose new age restrictions and marketing curbs starting in October 2026. ALP's aggressive growth strategy is therefore a race against a tightening regulatory clock. Its success will depend on establishing a significant market foothold before potential restrictions on flavors, nicotine strengths (currently often capped at 20mg), and advertising are fully implemented.

The Power Players Behind the Pouch

To understand ALP's confidence, one must look at its ownership and strategic alliances. ALP Supply Co. LLC is a joint venture between Turning Point Brands (NYSE: TPB) and the Tucker Carlson Network (TCN). This is not a typical corporate structure; it's a strategic fusion of industrial scale and media muscle.

Turning Point Brands provides the industry backbone—the manufacturing expertise, supply chain logistics, and experience navigating the complexities of regulated consumer products. TCN, on the other hand, brings a powerful and engaged audience. This structure allows ALP to build its brand narrative outside of traditional advertising channels, leveraging a media platform to cultivate a loyal consumer base that aligns with a specific worldview.

This powerful combination is amplified by a global partnership with UFC champion Conor McGregor. Framed as a "hostile takeover of a boring industry," the collaboration positions ALP as a challenger brand for consumers who value "performance, intentionality, and doing things their own way." With McGregor's access to a reported 80 million followers, ALP gains an instant and massive marketing reach that would take competitors years and hundreds of millions in ad spend to build. This celebrity-driven, culture-focused marketing is designed to cut through the noise and build the kind of brand affinity that its DTC model thrived on in the US.

A High-Stakes Public Health Debate

As ALP makes its European push, it lands squarely in the middle of a contentious public health debate. Proponents of harm reduction, including some public health bodies, view tobacco-free nicotine pouches as a significantly safer alternative for adult smokers who are unable or unwilling to quit nicotine entirely. They point to Sweden, where high oral nicotine use corresponds with the lowest smoking rates in Europe. The FDA's authorization of ZYN as a reduced-risk product in 2025 lent significant weight to this argument.

However, the rapid growth and slick marketing of brands like ALP raise serious concerns about youth uptake and the creation of a new generation of nicotine addicts. The World Health Organization warned in a May 2026 report that regulation is failing to keep pace with the industry's aggressive expansion. In the UK, studies already show rising awareness and use among 11-17 year-olds, fueled by what critics call trendy, lifestyle-oriented marketing.

While the products are tobacco-free, they are not risk-free. Nicotine is highly addictive and can harm adolescent brain development. Medical research also points to potential risks for oral health and the cardiovascular system from long-term use. ALP's high-profile marketing, particularly its association with a global sports icon, will inevitably face intense scrutiny from regulators and public health advocates who fear it will glamorize nicotine use for a younger demographic. The company's future in Europe will be defined not only by its ability to capture market share from ZYN and VELO, but by its capacity to navigate this ethical and regulatory tightrope. The brand's ambitious push into Europe is a high-reward venture, but one where the financial, regulatory, and public health risks are equally immense.